Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D4OL
|
|||
| Former ID |
DIB008155
|
|||
| Drug Name |
SC-002
|
|||
| Synonyms |
SC-004
Click to Show/Hide
|
|||
| Indication | Bacterial infection [ICD-11: 1A00-1C4Z; ICD-10: A00-B99] | Phase 1 | [1] | |
| Small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162.9] | Phase 1 | [2] | ||
| Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Phase 1 | [2], [3] | ||
| Company |
Taisho Pharmaceutical Co Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H12N8O5S3
|
|||
| Canonical SMILES |
C1C(=C(N2C(S1)C(C2=O)C(=O)NC(=NO)C3=NSC(=N3)N)C(=O)O)C=CC4=CSN=N4
|
|||
| InChI |
1S/C15H12N8O5S3/c16-15-18-10(21-31-15)9(20-28)17-11(24)7-12(25)23-8(14(26)27)5(3-29-13(7)23)1-2-6-4-30-22-19-6/h1-2,4,7,13,28H,3H2,(H,26,27)(H2,16,18,21)(H,17,20,24)/b2-1+/t7?,13-/m1/s1
|
|||
| InChIKey |
HFOMCBOZKJQJHK-CLIAQYSASA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02500914) SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.